APA (7th ed.) Citation

JS, F., T, J., O, R., KL, H., E, E., P, K., . . . A, H. (2023). Using EGFR amplification to stratify recurrent glioblastoma treated with immune checkpoint inhibitors. Cancer immunology, immunotherapy : CII, 72(6), 1893. https://doi.org/10.1007/s00262-023-03381-y

Chicago Style (17th ed.) Citation

JS, Friedman, et al. "Using EGFR Amplification to Stratify Recurrent Glioblastoma Treated with Immune Checkpoint Inhibitors." Cancer Immunology, Immunotherapy : CII 72, no. 6 (2023): 1893. https://doi.org/10.1007/s00262-023-03381-y.

MLA (9th ed.) Citation

JS, Friedman, et al. "Using EGFR Amplification to Stratify Recurrent Glioblastoma Treated with Immune Checkpoint Inhibitors." Cancer Immunology, Immunotherapy : CII, vol. 72, no. 6, 2023, p. 1893, https://doi.org/10.1007/s00262-023-03381-y.